RxDoctor Payments Data

Joseph Adongay, MD

Colon & Rectal Surgery · Evansville, INNPI 1144519430

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 22 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Hydrofera LLC at 35.6% of the total. Reporting peaked in 2019 at $266 and has fallen 64.4% since, to $95 in 2025. That places this record below the midpoint for colon & rectal surgery clinicians in IN, where the typical reported total is $1,741.

$420in general payments, 2019–2025

Across 22 payments — averaging $19.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Hydrofera LLC$150
  • Johnson & Johnson$74
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$69
  • Shire North American Group Inc$48
  • Medtronic$45
  • Intuitive Surgical$29
  • plus $5 from 1 others

What the payments were for

  • Food & beverage$420100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$420 in reported general payments places this provider in the 25th percentile of 54 colon & rectal surgery providers in Indiana.

See all colon & rectal surgery providers in Indiana

Medicare billing

Part B allowed, 2024
$545,730
Medicare patients
442
Services billed
3,710

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban11$4,207
Doxycycline Hyclate21$449
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav12$326
Cephalexin14$250
Tamsulosin Hcl12$138

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Evansville

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →